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Objective. To evaluate 2-hour lactate clearance as a prognostic marker in acute cardiorespiratory insuﬃciency. Design.P r o s p e c t i v e
observational study. Setting. Emergency Department (ED) and 16-bed medical High Dependency Unit (HDU). Methods and Main
Results. 95 consecutive admissions from the ED for acute cardiorespiratory insuﬃciency were prospectively enrolled. Arterial
lactate concentration was assessed at ED arrival and 1, 2, 6, and 24 hours later. The predictive value of 2-hour lactate clearance
was evaluated for negative outcomes deﬁned as hospital mortality or need for endotracheal intubation versus positive outcomes
deﬁned as discharge or transfer to a general medical ward. Logistic regression and ROC curves found 2-hour lactate clearance
>15% was a strong predictor of negative outcome (P<. 0001) with a sensitivity of 86% (95%CI = 67%–95%) and a speciﬁcity
of 91% (95%CI = 82%–96%), Positive predictive value was 80% (95%CI = 61%–92%), and negative predictive value was 92%
(95%CI = 84%–98%). Conclusions. Systematic monitoring of lactate clearance at 2 hours can be used in to identify patients at
high risk of negative outcome and perhaps to tailor more aggressive therapy. Equally important is that a 2-hour lactate clearance
>15% is highly predictive of positive outcome and may reassure clinicians that the therapeutic approach is appropriate.
1.Introduction
Acute cardiorespiratory failure from any cause creates an
imbalance between energy supply, demand, and consump-
tion. A high lactate concentration associated with a low
blood pH is useful to depict the gravity of such a mismatch
[1]. Lactate overproduction can be promptly removed from
blood if renal and hepatic perfusion and function are near
normal [2, 3]. A huge bulk of research has been focused
on lactate production/removal in critically ill patients. Some
evidence suggests that persistent elevation in lactate is
associated with high mortality rate [4–6]. It is generally
agreed that the longer lactate levels remain high, the worse
the prognosis [7, 8]. However, a question remains regarding
the timing needed to guide the therapy based on evaluation
of lactate clearance [9].
Followingtheconceptof“Early-Goal-Directed-Therapy”
(EGDT) [10], one should be satisﬁed if the therapeutic
approach determines a lactate clearance greater than 20%
within 6 hours of treatment (LACT-6h-clearance). Indeed,
this metabolic goal is acceptable when the lactate over-
p r o d u c t i o nr e ﬂ e c t sah y p e r m e t a b o l i cs t a t e ,a si ns e p t i c
patients.However,LACT-6h-clearanceislessusefulinassess-
ing the response to treatment when an increase in lactate
occurs rapidly, as in patients with acute cardiorespiratory
failure.
We hypothesized that, in these patients, an earlier lactate
clearanceshouldbeusefultoassessthemetabolicresponseto
therapy and to identify patients able to reverse the metabolic
derangement. A secondary hypothesis was that failure to
rapidly resolve the oxygen debt, indicated by poor lactate
clearance, would be correlated with negative outcome. For
this purpose a prospective series of patients consecutively
admitted to the Emergency Department with acute car-
diorespiratory failure underwent a standardized therapeutic
approach and the metabolic response was assessed by lactate2 Critical Care Research and Practice
clearance after 2 hours of treatment (LACT-2h-clearance).
The ﬁrst aim of the study was to evaluate the utility of
short-termlactateclearanceinacutecardiorespiratoryfailure
patients and the second was to assess its value in predicting
patient outcome.
2.MaterialsandMethods
2.1. Inclusion Criteria. Acute decompensated cardiac failure
and/or “acute-on-chronic” respiratory failure. Acute cardiac
failure was deﬁned as a condition with decreased tissue
perfusion other than simple hypovolemia in which volume
and/or drugs that improve cardiac performance and/or
restore abnormal vascular tone could be prescribed. Respira-
toryfailurewasdeﬁnedasoxygensaturationoflessthan90%
despite supplementary oxygen with or without hypercapnia.
These entities were deﬁned clinically in the emergency
department with at least 4 out of 6 of the following
parameters:
Respiratory rate >25
Heart rate >130
Systolic blood pressure <90
SpO2 <90% at FiO2 of 0.30
Bibasal crepitations on auscultation
Arterial blood lactate >2mmol/L.
2.2. Exclusion Criteria
Pneumonia deﬁned as
lung inﬁltrate on the chest radiograph associ-
atedwithatlesttwoofthefollowingconditions:
fever, leucocytosis, purulent sputum in which
a Gram stain showed one or more types of
bacteria.
Sepsis syndrome deﬁned as
positive blood cultures and/or fever of >38◦C
together with positive cultures from suspected
sources.
Renal dialysis
Glasgow coma scale <8
Criteria for immediate intubation for cardiopul-
monary resuscitation
Inotropic support with catecolamines at baseline
Failure of two or more additional organs deﬁned as
Bilirubin >2mg/dL, creatinine >2mg/dL or
creatinine clearance <50mL/min, platelets
<100.000/mmc, Hb < 7.5g/dL.
Electrocardiogram instability with evidence of life-
threatening ventricular arrhythmia.
2.3. Patients and Study Design. Ninety ﬁve consecutive
patients with acute cardiorespiratory insuﬃciency, admit-
ted from an emergency department to a 16-bed medical
ICU/HDU during 2008, were prospectively enrolled in the
study. Anthropometric and functional characteristics of the
patients are listed in Table 1.
Thepreliminarydiagnosiswasmadeaccordingtoclinical
history, physical examination, arterial blood gas, and chest
radiography. Subsequent investigations and monitoring took
place in the Medical Intensive Care or High Dependency
Unit (ICU/HDU) depending on acuity. The following data
were collected for all patients. Blood pressure, heart and
respiratory rate, Glasgow Coma Scale [11] and APACHE II
score [12], arterial blood gases and lactate, full blood count,
biochemistry panel, ECG monitoring, and ecocardiographic
evaluation.
3. Interventions
Gas exchange and lactate blood concentration were assessed
at ED arrival and 1, 2, 6, and 24 hours later. Two-hour lactate
clearance was calculated as
(Lactate start − lactate 2 hour)
lactate start (%)
. (1)
Blood gas-analysis and arterial lactate were performed by
intermittent blood sampling and co-oximetry (Blood Gas
Analyzer, Bayer Health Care Rapid Lab 1265). Inspired
fractional O2 concentration (FiO2) was recorded.
All patients were treated according to standard practice
in our ICU. Protocols for hemodynamic treatment including
inotropic support with dobutamine or phosphodiesterase
inhibitors,noninvasivepositivepressureventilation(NPPV),
light sedation, management of blood glucose, water, and
electrolytederangements wereused. Nopatients in ourstudy
were treated with lactate containing solutions, which might
have falsely elevated lactate levels.
The criteria for patients who underwent NPPV were
tachypnea with a respiratory rate greater than 25bpm,
pH7.10–7.35, and PaCO2 > 50mmHg. Continuous or bi-
level positive pressure support were chosen at the discretion
of the treating physician and adapted to response of the
patient. The criteria to determine when ventilator assistance
was discontinued were normal mental status, hemodynamic
stability,respiratoryratebelow25bpm,absenceofactivation
of accessory respiratory muscles and paradoxical abdominal
motion, arterial pH > 7.33, PaCO2 < 70mmHg, PaO2 >
55mmHg with FIO2 > 0.35 without ventilatory support.
The patients were discharged from the ICU/HDU when
NPPV was switched to oxygen therapy with FIO2 < 0.35
for 24h at least and the patients met the following criteria:
cardiorespiratory stability, respiratory rate below 25bpm,
pH > 7.35, PaO2 > 55mmHg, PaCO2 < 70mmHg, absence
of fever, leucocytosis, purulent sputum, and metabolic
complications. An independent clinical team not involved in
the research protocol decided about the discharge.
Primary outcome measures were hospital mortality or
endotracheal intubation (negative outcome) and discharge
or transfer to a general medical ward (positive outcome).Critical Care Research and Practice 3
4.StatisticalAnalysis
The data are expressed as mean and standard deviation
for continuous variables, medians, and interquartile range
(1st–3rd) for ordinal variables and numbers and frequencies
for nominal variables. Normality of data distribution was
appraised with Kolmogorov-Smirnov test. Homoscedicity
was tested with Levene median test with Lilliefors correction.
Based on pilot data and previous works on the prognostic
value of lactate in the critically ill [4, 10, 13], the study was
powered for an expected sensitivity of 90% with a minimal
acceptable conﬁdence limit of 75% [14, 15].
Factors likely to aﬀect outcome were recorded at the
outset. These included age >70 years, presence of severe
underlying diseases (cancer, pre-existing hepatic, or renal
insuﬃciency) presence of shock, acute renal failure, and
baseline laboratory parameters. Factors correlated with neg-
ative outcome at P<. 25 (chi-square or Fisher’s exact test,
as appropriate) were included in a logistic regression model
with the lactate clearance variables. A backward procedure
was then used to discard the nonsigniﬁcant variables from
the analysis. Sensitivity, speciﬁcity, and predictive values
were calculated according to standard formulae. Receiver
operating characteristics curves (ROC) were constructed
to evaluate the reliability of 2-hour lactate clearance as
prognostic factor. P<. 05 was considered signiﬁcant.
All statistical analyses were performed with SPSS 15.0 for
windows.
5. Results
A total of 95 patients were included in the study. All patients
had a history of signiﬁcant underlying pathology, sixty-
three had ischemic heart disease (68%), thirty-nine patients
had COPD (42%), thirty-ﬁve had type 2 diabetes (42%),
and twelve had chronic renal failure (8.7%). At enrolment
56 patients were in acute pulmonary oedema (68%), 25
patients had acute respiratory failure for severe exacerbation
of COPD (21%), 7 were in cardiogenic shock (6%), and
5 patients presented with acute myocardial infarction. 34
patients required noninvasive positive pressure ventilation
(NPPV) (43%). The overall negative outcome rate was
30% (28/95) 12% hospital mortality (11/95). 25 patients
required endotracheal intubation and of those 10 (40%)
died during their hospital stay. Lactate at baseline was not
diﬀerent between groups but 2-hour lactate and 2-hour
lactate clearance were signiﬁcantly worse in patients with
negative outcomes (Table 1).
The odds ratio for both elevated 2 hour lactate (7.73, P =
.002) and impaired LACT-2h-clearance (16.11, P<. 0001)
are highly signiﬁcant for negative outcome but LACT-2h-
clearance appears superior. The odds ratios of selected risk
factors are displayed in Table 2.
Figure 1 illustrates ROC curves for LACT-2h-clearance.
It demonstrates the reliability of LACT-2h-clearance as a
predictor of negative outcome, indicating that the best
compromise between sensitivity and speciﬁcity was obtained
for a lactate clearance of 15%. The global reliability of this
test to predict mortality is quite good, as conﬁrmed by the
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Figure 1: ROC curve for LACT-2h-clearance.
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outcome.
valueoftheareaundertheROC(AUROC)curveof0.86(P ≤
.0001; 95%CI 0.77–0.96) which is comparable to the values
previously reported for other risk factors of mortality in
similarstudies[13].Figure 2displaysagraphicalcomparison
of mean LACT-2h-clearance between patients with positive
and negative outcomes.
When <15% is used as a cut oﬀ, LACT-2h-clearance
accurately predicted negative outcome with a sensitivity4 Critical Care Research and Practice
Table 1: Patient characteristics.
Variables Patients (n = 95) Positive outcome (n = 67) Negative outcome (n = 28) P
Age (mean ± SD) 76.1 ±9.47 5 .5 ±9.27 7 .8 ±9.8N S
M/F 43/52 28/39 5/8 NS
Apache II score 19.4 ±4.61 9 .3 ±4.21 9 .8 ±5.3N S
Vital parameters
Heart rate bpm 114 ±30.2 117.3 ±27.8 106.0 ±34.7N S
Respiratory rate 34.4 ±6.83 5 .4 ±6.33 2 .3 ±7.6N S
MAP mmHg 113.5 ±32.8 115.6 ±29.19 4 .0 ±29.3 P<. 05
∗
Laboratory values
WBC, mm3 13.3 ±5.41 3 .3 ±5.31 3 .0 ±5.8N S
HTC, % 37.8 ±7.53 8 .5 ±7.23 4 .2 ±8.2N S
Creatinine, mg/dL 1.37 ±0.61 .36 ±0.75 1.43 ±0.3N S
pH 7.25 ± 0.14 7.24 ±0.08 7.26 ±0.16 NS
pO2, mmHg 63.4 ±22.56 7 .0 ±33.16 1 .9 ±16.3 P<. 05
∗
pCO2, mmHg 51.4 ±20.65 1 .1 ±17.65 2 .8 ±26.6N S
HCO3,m E q / L 2 1 .5 ±5.82 1 .2 ±5.12 2 .5 ±7.1N S
Lactate start, mmol/L 4.7 ±2.64 .7 ±2.44 .7 ±2.9N S
Lactate 2h, mmol/L 3.0 ±2.02 .2 ±0.94 .7 ±2.8 P<. 05
∗
Lactate clearance at 2 hours(%) 27 ±43 43 ±30 −11 ± 47 P<. 05
∗
∗P<. 05, Student T-test; NS, Not Signiﬁcant.
MAP: mean arterial pressure, WBC: white blood count, HTC: hematocrit.
Table 2: Relationship between risk factors and negative outcome.
Variables Positive outcome (n = 67) Negative outcome (n = 28) Odds Ratio (95% CI) P
Age >75 41 (61%) 20 (71%) 1.59 (0.79–3.17) .34
Male/Female 28/39 (42/58%) 15/13 (54/46%) N/A .57
IHD 47 (29%) 16 (31%) 0.57 (0.27–1.16) .23
Cardiogenic shock 3 (5%) 4 (14%) 3.55 (0.74–16.93) .07
Myocardial Infarction 4 (6%) 1 (4%) 0.59 (0.06–5.45) .67
COPD 29 (44%) 10 (38%) 0.73 (0.31–1.69) .49
Renal Failure 10 (32%) 2 (46%) 0.44 (0.09–2.13) .31
p02 < 60 at 2 hours 7 (17%) 3 (15% ) 1.03 (0.25–4.26) .96
Hemaglobin <10g/dL 5 (7%) 8 (29%) 4.10 (1.21–13.86) .02
p02 < 60mmHg at presentation 34(38%) 17 (84.6) 1.50 (0.72–3.11) .005
MAP <90 at presentation 9 (13%) 13(46%) 5.58 (2.01–15.52) .001
Serum lactate >2.5mmol/L at 2 hours 23 (37%) 25 (82%) 7.73 (2.60–22.90) .0002
Lactate clearance <20% at 2 hours 9 (21%) 20 (69.2) 16.11 (6.53–39.70) <.0001
IHD-ischemic heart disease; COPD–chronic obstructive pulmonary disease; CI-conﬁdence interval.
of 86% (95%CI = 67%–95%) and a speciﬁcity of 91%
(95%CI = 82%–96%). Positive predictive value was 80%
(95%CI = 61%–92%) and negative predictive value was
92% (95%CI = 84%–98%). Two-hour lactate clearance also
outperforms other markers commonly used in critical care
such as baseline lactate (AUROC = 0.46), 2-hour base excess
(AUROC = 0.66), shock index (AUROC = 0.61) and MAP
(AUROC = 0.75). Two-hour lactate measurements produced
A U R O Co f0 . 8 4b u ti t ss e n s i t i v i t ya n ds p e c i ﬁ c i t yw e r e
inferior to LACT-2h-clearance given that a cut oﬀ of 2.5
mg/dL returned a sensitivity of 82% but a speciﬁcity of only
64%.
Variables identiﬁed by the backward logistic regression
model as signiﬁcantly correlated with negative outcome were
LACT-2h-clearance less than 15%, 2-hour lactate and MAP
less than 90 at presentation. The log likelhood ratio of
LACT-2h-clearance less than 15%, was 40.08 (P<. 001).
Other laboratory values, catacolamine use, age, sex, and
comorbiditesdidnotpredictnegativeoutcomeinthismodel.
6. Discussion
The most important result of the present investigation was
that LACT-2h-clearance can be feasible and clinically usefulCritical Care Research and Practice 5
as a predictive tool in cardiorespiratory insuﬃciency. Under
the experimental conditions of this study it seems that a
cut-oﬀ of <15% LACT-2h-clearance is predictive of negative
outcome. This measure proved robust even when lactate
levels were only mildly elevated at baseline (<3mmol/L).
Lactate clearance deserves the same diagnostic relevance
of other noninvasive markers of O2 delivery/consump-
tion/demand mismatch. While tissue pH, O2-saturation,
PCO2, and (prospectively) NADH monitoring could oﬀer
a precise “local” picture of cellular dysoxia [16], lactate
does not. Nevertheless the systematic checking of 2-hour
lactate clearance could be used to tailor the therapy in
many cases of cardiac or respiratory insuﬃciency. It seems
to mirror quite precisely hepatic and renal function and
perfusion [2, 17] in many critically ill patients. It cannot
be substituted by any other single parameter derived from
arterial blood gas analysis [18]. Reduced O2-delivery is
compatible with aerobic respiration if oxygen consumption
is simultaneously decreased; this is not an acidifying process
“per se” [19]. On the other hand, there are deﬁnite “time-
windows” in septic syndromes, where the hyper metabolism
produces high blood lactate concentrations, in patients who
are not yet acidotic. On the contrary, pure acute cardiac
or respiratory insuﬃciencies can be considered acid and
lactate producing syndromes, which are mostly associated
with reduced acid and lactate removal. Moreover the eﬀects
of some therapies (ﬂuid management, inotropes, ventilation,
etc.) are not always predictable, due to intrinsic myocardial
O2-consumption [20] and heart/lung/metabolism interac-
tions. Often even invasive hemodynamic parameters can be
puzzling.
Our patient cohort is made up predominantly of elderly
patients with multiple comorbidities, which is representative
of an increasingly large segment of the general population
and of ICU patients. In such patients invasive ventilation is
often better avoided if possible [21]. The decision to include
patients with either cardiac and/or respiratory insuﬃciency
was based on the frequent coexistence of these pathologies
and the diﬃculty in precisely diﬀerentiating these entities
in the emergency department. A robust early prognostic
marker, such as LACT-2h-clearance, to identify patients
with acute cardiorespiratory insuﬃciency at high risk of
negative outcome irrespective of the ultimate diagnosis is
an attractive clinical tool. In keeping with EGDT LACT-
2h-clearance may provide a target for clinicians to tailor
more aggressive therapy for patients at higher risk of
negative outcome. Of equal importance is the identiﬁcation
of patients in whom the current therapy is working and
who are likely to have a positive outcome. To our knowledge
our work is the ﬁrst to examine the prognostic value
of lactate at 2 hours in this increasingly large patient
population. Indeed the cut oﬀ of 15% clearance of serum
lactate at 2 hours is lower and measured signiﬁcantly
sooner than the bulk of studies investigating the prognostic
value of lactate. This is because much of the work in
this ﬁeld has been in relation to septic patients who
respond more slowly to therapy than cardiorespiratory
patients.
7. Study Limitations
This study has several limitations. First of all, there is a “lag
phase” between the initial resolution of the cardiorespiratory
crisis and the descending slope of lactate concentration.
This is due to a “wash-out” phenomenon linked to ﬂow
restoration, plus the O2-debt which must be repaid by the
liverandkidneysbeforetheycanrestartthecellular“machin-
ery.” Second, it should be considered that the fast-responder
organs are usually pouring their lactate into the blood well
before it is detectable on any arterial sample, so that a precise
evaluation should be done drawing the eﬄuent blood of
each organ (e.g., internal jugular or coronary veins). Third,
the lactate/pyruvate (=NADH/NAD) ratio is not routine
evaluation, but should be done whenever a hypermetabolic
state is suspected [22, 23]. Fourth, there are some drugs and
inherited metabolic syndromes which can complicate the
picture. In particular inotropic agents are known to increase
serum lactate levels. However, there was no correlation in
our study between the use of catecholamines and negative
outcome as evidenced by the logistic regression analysis.
We do not have data to assess how closely the care
team complied with standard protocols and although the
same team cared for all patients in the study, there may
have been slight variability in the approach by individual
clinicians who were in charge of the patients regarding
parameters such as inotrope dosage or ventilator settings.
These changes may have lead to diﬀerences in the quality
of care provided, which could introduce a degree of bias
into the results. Finally the study included patients with
cardiorespiratory failure rather than the patients with a
speciﬁc pathological diagnosis. Although the results indicate
that LACT-2h-clearance predicts outcome irrespective of
the underlying pathology the study was not adequately
powered to perform subgroup analysis. A larger validation
study would be necessary to conﬁrm the predictive values
suggested by the current data in speciﬁc patient subgroups
with purely cardiac or respiratory pathology.
8. Conclusions
The systematic monitoring of lactate clearance at 2 hours
should be clinically useful in cases of acute cardiac or
respiratory insuﬃciency to identify patients at high risk of
negativeoutcomeand,potentially,toincreasetheintensityof
the therapeutic approach. Finally, a 2-hour lactate clearance
>15% is highly predictive of positive outcome and may
reassure clinicians that the therapeutic approach is appropri-
ate. However, larger, prospective randomized studies will be
needed to validate this hypothesis.
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